• June 16-19, 2025
  • Boston Convention & Exhibition Center

Sessions

Loading

Optimizing the Investability of Your Lead Program: Data-Driven Approaches for Pipeline Prioritization

Tuesday, June 04, 2024
Breakout Session
Business Development and Finance
32AB
Identifying a lead indication, development candidate selection and pipeline prioritization are critical decisions for all biotech companies. This panel will focus on key strategies and considerations to optimize the transition from the preclinical stage in development to clinical stage. Critical topics this discussion will cover highlight data-driven approaches to increase probability of success, with particular attention to trade-offs between speed to clinic and additional data, attention to capital needs/constraints, speed to market and market size, appropriate and timely regulatory path identification, strategies to engage with the FDA, as well as some IRA considerations.
Moderator
Drew Cutshaw, MD
Senior Associate, Medical Officer
Pappas Capital
Speakers
Mike Grey
Chairman
Plexium
Susan Lenderts
Head of Life Sciences
SAS Institute, INC
Ben Davis
Vice President, Corporate Alliances
IQVIA
Lauren Crawford Shaver
Head of Healthcare and Life Sciences for the Americas, Senior Managing Director
FTI Consulting
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS